Sleeping Aids Market (By Product Type: Mattresses and Pillows, Sleep Laboratories, Medication, Sleep Apnea Devices; By Sleep Disorder: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
Global Sleeping Aids Market is estimated to reach $96 billion by 2024; growing at a CAGR of 6.3 % from 2016 to 2024. Sleeping aids are drugs and medical devices used to identify and treat different sleeping disorders. Sleep apnea, insomnia, daytime sleepiness are indications of sleep disorder. Human health is harmfully affected by these sleep disorders which can cause various chronic diseases, such as high blood pressure, diabetes, arthritis, stroke, and obesity. It is important to treat and diagnose these sleep disorders to avoid major adverse effects on human health.
Changing consumer lifestyle, rise in demand for sleeping pills, increase in geriatric and obese population, and increasing disposable income are the factors boosting the growth of the global sleeping aids market. Moreover, advanced technologies and rising awareness about sleeping disorders would provide several market opportunities in coming years. Though, various side effects of sleep aids medication and patent expiration might hamper the growth of the market.
The global sleeping aids market is segmented on basis of product and sleep disorder. The sleeping aids market is segmented by product as mattresses and pillows, sleep apnea devices, medication (prescription based drugs, OTC drugs, and herbal drugs), sleep laboratories, and others. Further, by sleep disorder the market is segmented as insomnia, restless legs syndrome, sleep apnea, narcolepsy, sleep walking, and other sleep disorders.
Geographically, global sleeping aids market is segmented into North America, Europe, Asia Pacific, Rest of the World (RoW) North America is further bifurcated in U.S., Canada, and Mexico whereas Europe segment consist of UK, Russia, Germany, France, Italy, and others. Asia-Pacific is segmented into India, China, Japan, South Korea, and others while RoW is bifurcated into South America, Middle East, and Africa.
The key market players include CareFusion Corporation, Pfizer, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Teva Pharmaceutical Industries Limited, Natus Medical Incorporated, Compumedics Limited, Merck And Co., Sanofi, and Serta International, among others.
THE KEY TAKEAWAYS FROM THE REPORT
Product Segments
Changing consumer lifestyle, rise in demand for sleeping pills, increase in geriatric and obese population, and increasing disposable income are the factors boosting the growth of the global sleeping aids market. Moreover, advanced technologies and rising awareness about sleeping disorders would provide several market opportunities in coming years. Though, various side effects of sleep aids medication and patent expiration might hamper the growth of the market.
The global sleeping aids market is segmented on basis of product and sleep disorder. The sleeping aids market is segmented by product as mattresses and pillows, sleep apnea devices, medication (prescription based drugs, OTC drugs, and herbal drugs), sleep laboratories, and others. Further, by sleep disorder the market is segmented as insomnia, restless legs syndrome, sleep apnea, narcolepsy, sleep walking, and other sleep disorders.
Geographically, global sleeping aids market is segmented into North America, Europe, Asia Pacific, Rest of the World (RoW) North America is further bifurcated in U.S., Canada, and Mexico whereas Europe segment consist of UK, Russia, Germany, France, Italy, and others. Asia-Pacific is segmented into India, China, Japan, South Korea, and others while RoW is bifurcated into South America, Middle East, and Africa.
The key market players include CareFusion Corporation, Pfizer, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Teva Pharmaceutical Industries Limited, Natus Medical Incorporated, Compumedics Limited, Merck And Co., Sanofi, and Serta International, among others.
THE KEY TAKEAWAYS FROM THE REPORT
- The report will provide detailed analysis of Global Sleeping Aids Market with respect to major segments such as product and sleep disorder
- The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024
- Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
- An exhaustive regional analysis of Global Sleeping Aids Market has been included in the report
- Profile of the key players in the Global Sleeping Aids Market will be provided, which include key financials, product & services, new developments and business strategies
Product Segments
- Mattresses And Pillows
- Sleep Apnea Devices
- Medication
- Prescription Based Drugs
- OTC drugs
- Herbal Drugs
- Sleep Laboratories
- Others
- Insomnia
- Restless Legs Syndrome
- Sleep Apnea
- Narcolepsy
- Sleep Walking
- Other Sleep Disorders
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Russia
- Germany
- France
- Italy
- Others
- Asia-Pacific
- India
- China
- Japan
- South Korea
- Others
- RoW
- South America
- Middle East
- Africa
CHAPTER 1 PREFIX
1.1 Market Scope
1.2 Report Description
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 In-house Data Modeling
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OUTLINE
3.1 Market Inclination, Trend, Outlook and Viewpoint
3.2 Market Share Analysis: Company’s Competitive Scenario
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Impact Analysis
3.3.2 Restraints
3.3.2.1 Impact Analysis
3.3.3 Opportunities
CHAPTER 4 SLEEPING AIDS MARKET BY PRODUCT: MARKET SIZE AND FORECAST, 2015 – 2024
4.1 Overview
4.2 Mattresses and Pillows
4.2.1 Current Trend and Analysis
4.2.2 Market Size and Forecast
4.3 Sleep Laboratories
4.3.1 Current Trend and Analysis
4.3.2 Market Size and Forecast
4.4 Medication
4.3.1 Current Trend and Analysis
4.4.2 Market Size and Forecast
4.4.3 Prescription Based Drugs
4.4.3.1 Market Size and Forecast
4.4.4 Herbal Drugs
4.4.4.1 Market Size and Forecast
4.4.5 OTC Drugs
4.4.5.1 Market Size and Forecast
4.5 Sleep Apnea Devices
4.5.1 Current Trend and Analysis
4.5.2 Market Size and Forecast
4.6 Other Products
4.6.1 Current Trend and Analysis
4.6.2 Market Size and Forecast
CHAPTER 5 SLEEPING AIDS MARKET BY SLEEP DISORDER: MARKET SIZE AND FORECAST, 2015 – 2024
5.1 Overview
5.2 Insomnia
5.2.1 Current Trend and Analysis
5.2.2 Market Size and Forecast
5.3 Sleep Apnea
5.3.1 Current Trend and Analysis
5.3.2 Market Size and Forecast
5.4 Restless Legs Syndrome
5.4.1 Current Trend and Analysis
5.4.2 Market Size and Forecast
5.5 Narcolepsy
5.5.1 Current Trend and Analysis
5.5.2 Market Size and Forecast
5.6 Sleep Walking
5.6.1 Current Trend and Analysis
5.6.2 Market Size and Forecast
5.7 Other Sleep Disorders
5.7.1 Current Trend and Analysis
5.7.2 Market Size and Forecast
CHAPTER 6 SLEEPING AIDS MARKET BY GEOGRAPHY: MARKET SIZE AND FORECAST, 2015 – 2024
6.1 Overview
6.2 North America
6.2.1 Current Trend and Analysis
6.2.2 Market Size and Forecast
6.2.3 US
6.2.3.1 Market Size and Forecast
6.2.4 Canada
6.2.4.1 Market Size and Forecast
6.2.5 Mexico
6.2.5.1 Market Size and Forecast
6.3 Europe
6.3.1 Current Trend and Analysis
6.3.2 Market Size and Forecast
6.3.3 Germany
6.3.3.1 Market Size and Forecast
6.3.4 France
6.3.4.1 Market Size and Forecast
6.3.5 United Kingdom
6.3.5.1 Market Size and Forecast
6.3.6 Italy
6.3.6.1 Market Size and Forecast
6.3.7 Others
6.3.7.1 Market Size and Forecast
6.4 Asia-Pacific
6.4.1 Current Trend and Analysis
6.4.2 Market Size and Forecast
6.4.3 China
6.4.3.1 Market Size and Forecast
6.4.4 India
6.4.4.1 Market Size and Forecast
6.4.5 Japan
6.4.5.1 Market Size and Forecast
6.4.6 South Korea
6.4.6.1 Market Size and Forecast
6.4.7 Others
6.4.7.1 Market Size and Forecast
6.5 RoW
6.5.1 Current Trend and Analysis
6.5.2 Market Size and Forecast
6.5.3 South America
6.5.3.1 Market Size and Forecast
6.5.4 Middle East
6.5.4.1 Market Size and Forecast
6.5.5 Africa
6.5.5.1 Market Size and Forecast
CHAPTER 7 COMPANY PROFILES
7.1 Takeda Pharmaceutical Company Limited
7.2 CareFusion Corporation
7.3 Pfizer
7.4 Teva Pharmaceutical Industries Limited
7.5 Natus Medical Incorporated
7.6 Compumedics Limited
7.7 Merck And Co.
7.8 Sanofi
7.9 GlaxoSmithKline Plc
7.10 Serta International
1.1 Market Scope
1.2 Report Description
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 In-house Data Modeling
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OUTLINE
3.1 Market Inclination, Trend, Outlook and Viewpoint
3.2 Market Share Analysis: Company’s Competitive Scenario
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Impact Analysis
3.3.2 Restraints
3.3.2.1 Impact Analysis
3.3.3 Opportunities
CHAPTER 4 SLEEPING AIDS MARKET BY PRODUCT: MARKET SIZE AND FORECAST, 2015 – 2024
4.1 Overview
4.2 Mattresses and Pillows
4.2.1 Current Trend and Analysis
4.2.2 Market Size and Forecast
4.3 Sleep Laboratories
4.3.1 Current Trend and Analysis
4.3.2 Market Size and Forecast
4.4 Medication
4.3.1 Current Trend and Analysis
4.4.2 Market Size and Forecast
4.4.3 Prescription Based Drugs
4.4.3.1 Market Size and Forecast
4.4.4 Herbal Drugs
4.4.4.1 Market Size and Forecast
4.4.5 OTC Drugs
4.4.5.1 Market Size and Forecast
4.5 Sleep Apnea Devices
4.5.1 Current Trend and Analysis
4.5.2 Market Size and Forecast
4.6 Other Products
4.6.1 Current Trend and Analysis
4.6.2 Market Size and Forecast
CHAPTER 5 SLEEPING AIDS MARKET BY SLEEP DISORDER: MARKET SIZE AND FORECAST, 2015 – 2024
5.1 Overview
5.2 Insomnia
5.2.1 Current Trend and Analysis
5.2.2 Market Size and Forecast
5.3 Sleep Apnea
5.3.1 Current Trend and Analysis
5.3.2 Market Size and Forecast
5.4 Restless Legs Syndrome
5.4.1 Current Trend and Analysis
5.4.2 Market Size and Forecast
5.5 Narcolepsy
5.5.1 Current Trend and Analysis
5.5.2 Market Size and Forecast
5.6 Sleep Walking
5.6.1 Current Trend and Analysis
5.6.2 Market Size and Forecast
5.7 Other Sleep Disorders
5.7.1 Current Trend and Analysis
5.7.2 Market Size and Forecast
CHAPTER 6 SLEEPING AIDS MARKET BY GEOGRAPHY: MARKET SIZE AND FORECAST, 2015 – 2024
6.1 Overview
6.2 North America
6.2.1 Current Trend and Analysis
6.2.2 Market Size and Forecast
6.2.3 US
6.2.3.1 Market Size and Forecast
6.2.4 Canada
6.2.4.1 Market Size and Forecast
6.2.5 Mexico
6.2.5.1 Market Size and Forecast
6.3 Europe
6.3.1 Current Trend and Analysis
6.3.2 Market Size and Forecast
6.3.3 Germany
6.3.3.1 Market Size and Forecast
6.3.4 France
6.3.4.1 Market Size and Forecast
6.3.5 United Kingdom
6.3.5.1 Market Size and Forecast
6.3.6 Italy
6.3.6.1 Market Size and Forecast
6.3.7 Others
6.3.7.1 Market Size and Forecast
6.4 Asia-Pacific
6.4.1 Current Trend and Analysis
6.4.2 Market Size and Forecast
6.4.3 China
6.4.3.1 Market Size and Forecast
6.4.4 India
6.4.4.1 Market Size and Forecast
6.4.5 Japan
6.4.5.1 Market Size and Forecast
6.4.6 South Korea
6.4.6.1 Market Size and Forecast
6.4.7 Others
6.4.7.1 Market Size and Forecast
6.5 RoW
6.5.1 Current Trend and Analysis
6.5.2 Market Size and Forecast
6.5.3 South America
6.5.3.1 Market Size and Forecast
6.5.4 Middle East
6.5.4.1 Market Size and Forecast
6.5.5 Africa
6.5.5.1 Market Size and Forecast
CHAPTER 7 COMPANY PROFILES
7.1 Takeda Pharmaceutical Company Limited
7.2 CareFusion Corporation
7.3 Pfizer
7.4 Teva Pharmaceutical Industries Limited
7.5 Natus Medical Incorporated
7.6 Compumedics Limited
7.7 Merck And Co.
7.8 Sanofi
7.9 GlaxoSmithKline Plc
7.10 Serta International
